Lipkowitz S - Search Results

1

Cbl-3-deficient mice exhibit normal epithelial development.

Griffiths EK, Sanchez O, Mill P, Krawczyk C, Hojilla CV, Rubin E, Nau MM, Khokha R, Lipkowitz S, Hui CC, Penninger JM. Griffiths EK, et al. Among authors: lipkowitz s. Mol Cell Biol. 2003 Nov;23(21):7708-18. doi: 10.1128/MCB.23.21.7708-7718.2003. Mol Cell Biol. 2003. PMID: 14560016 Free PMC article.

2

Comparative genomic organization of the cbl genes.

Nau MM, Lipkowitz S. Nau MM, et al. Among authors: lipkowitz s. Gene. 2003 Apr 10;308:103-13. doi: 10.1016/s0378-1119(03)00471-2. Gene. 2003. PMID: 12711395

3

Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b.

Davies GC, Ettenberg SA, Coats AO, Mussante M, Ravichandran S, Collins J, Nau MM, Lipkowitz S. Davies GC, et al. Among authors: lipkowitz s. Oncogene. 2004 Sep 16;23(42):7104-15. doi: 10.1038/sj.onc.1207952. Oncogene. 2004. PMID: 15273720

4

Apoptosis and the treatment of breast cancer.

Cuello MA, Nau M, Lipkowitz S. Cuello MA, et al. Among authors: lipkowitz s. Breast Dis. 2002;15:71-82. doi: 10.3233/bd-2002-15108. Breast Dis. 2002. PMID: 15687647

5

A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.

Peschard P, Ishiyama N, Lin T, Lipkowitz S, Park M. Peschard P, et al. Among authors: lipkowitz s. J Biol Chem. 2004 Jul 9;279(28):29565-71. doi: 10.1074/jbc.M403954200. Epub 2004 Apr 29. J Biol Chem. 2004. PMID: 15123609 Free article.

6

WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation.

Magnifico A, Ettenberg S, Yang C, Mariano J, Tiwari S, Fang S, Lipkowitz S, Weissman AM. Magnifico A, et al. Among authors: lipkowitz s. J Biol Chem. 2003 Oct 31;278(44):43169-77. doi: 10.1074/jbc.M308009200. Epub 2003 Aug 7. J Biol Chem. 2003. PMID: 12907674 Free article.

7

Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl).

Zeng S, Xu Z, Lipkowitz S, Longley JB. Zeng S, et al. Among authors: lipkowitz s. Blood. 2005 Jan 1;105(1):226-32. doi: 10.1182/blood-2004-05-1768. Epub 2004 Aug 17. Blood. 2005. PMID: 15315962 Free article.

8

Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination.

Zhang J, Bárdos T, Li D, Gál I, Vermes C, Xu J, Mikecz K, Finnegan A, Lipkowitz S, Glant TT. Zhang J, et al. Among authors: lipkowitz s. J Immunol. 2002 Sep 1;169(5):2236-40. doi: 10.4049/jimmunol.169.5.2236. J Immunol. 2002. PMID: 12193687

9

Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor.

Tan AR, Yang X, Hewitt SM, Berman A, Lepper ER, Sparreboom A, Parr AL, Figg WD, Chow C, Steinberg SM, Bacharach SL, Whatley M, Carrasquillo JA, Brahim JS, Ettenberg SA, Lipkowitz S, Swain SM. Tan AR, et al. Among authors: lipkowitz s. J Clin Oncol. 2004 Aug 1;22(15):3080-90. doi: 10.1200/JCO.2004.08.189. J Clin Oncol. 2004. PMID: 15284258

10

The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer.

Lipkowitz S. Lipkowitz S. Breast Cancer Res. 2003;5(1):8-15. doi: 10.1186/bcr541. Epub 2002 Oct 7. Breast Cancer Res. 2003. PMID: 12559039 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters